Cantor Fitzgerald Initiates Coverage on National Health Investors (NYSE:NHI)

Key Points

• Cantor Fitzgerald has upgraded National Health Investors (NYSE:NHI) to a "strong-buy" rating, indicating a positive outlook on the stock.
• Other analysts, including KeyCorp and Wells Fargo, have also raised their ratings and target prices for NHI, with a consensus price target of $84.83.
• In its latest earnings report, National Health Investors surpassed expectations by posting $1.22 earnings per share against a consensus estimate of $1.16.

Research analysts at Cantor Fitzgerald assumed coverage on shares of National Health Investors (NYSE:NHI - Get Free Report) in a report released on Wednesday, MarketBeat.com reports. The brokerage set an "overweight" rating and a $90.00 price target on the real estate investment trust's stock. Cantor Fitzgerald's price target indicates a potential upside of 12.57% from the company's previous close.

A number of other equities analysts have also commented on NHI. Truist Financial raised their price objective on shares of National Health Investors from $77.00 to $81.00 and gave the company a "buy" rating in a research report on Friday, August 15th. National Bankshares set a $90.00 target price on shares of National Health Investors in a research report on Wednesday. KeyCorp upgraded shares of National Health Investors from a "sector weight" rating to an "overweight" rating and set a $80.00 target price for the company in a research report on Thursday, July 10th. Wedbush upgraded shares of National Health Investors to a "strong-buy" rating in a research report on Wednesday, July 2nd. Finally, Wells Fargo & Company lifted their target price on shares of National Health Investors from $76.00 to $80.00 and gave the company an "equal weight" rating in a research report on Wednesday, August 27th. Two research analysts have rated the stock with a Strong Buy rating, two have assigned a Buy rating and one has given a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Buy" and an average target price of $84.83.

National Health Investors Stock Performance

Shares of NHI stock opened at $79.95 on Wednesday. National Health Investors has a one year low of $65.13 and a one year high of $82.86. The firm has a 50-day moving average of $76.32 and a 200-day moving average of $74.05. The company has a debt-to-equity ratio of 0.75, a current ratio of 10.91 and a quick ratio of 10.91. The company has a market cap of $3.80 billion, a P/E ratio of 25.54, a P/E/G ratio of 3.41 and a beta of 0.77.

National Health Investors (NYSE:NHI - Get Free Report) last posted its earnings results on Wednesday, August 6th. The real estate investment trust reported $1.22 earnings per share for the quarter, topping the consensus estimate of $1.16 by $0.06. The firm had revenue of $70.27 million during the quarter, compared to the consensus estimate of $86.46 million. National Health Investors had a net margin of 40.97% and a return on equity of 10.32%. The company's revenue was up 6.7% on a year-over-year basis. During the same quarter last year, the company earned $1.18 earnings per share. Equities research analysts forecast that National Health Investors will post 4.41 EPS for the current fiscal year.

Institutional Trading of National Health Investors

A number of hedge funds and other institutional investors have recently modified their holdings of the business. JPMorgan Chase & Co. lifted its stake in shares of National Health Investors by 305.2% in the 2nd quarter. JPMorgan Chase & Co. now owns 1,203,492 shares of the real estate investment trust's stock worth $84,389,000 after purchasing an additional 906,479 shares during the period. Norges Bank purchased a new position in shares of National Health Investors in the second quarter valued at $49,775,000. M Holdings Securities Inc. purchased a new position in National Health Investors during the second quarter worth $36,607,000. Balyasny Asset Management L.P. boosted its stake in National Health Investors by 66.9% during the second quarter. Balyasny Asset Management L.P. now owns 614,960 shares of the real estate investment trust's stock worth $43,121,000 after buying an additional 246,486 shares during the period. Finally, MetLife Investment Management LLC boosted its stake in shares of National Health Investors by 706.6% during the first quarter. MetLife Investment Management LLC now owns 213,730 shares of the real estate investment trust's stock valued at $15,786,000 after purchasing an additional 187,233 shares during the period. 62.51% of the stock is owned by hedge funds and other institutional investors.

About National Health Investors

Incorporated in 1991, National Health Investors, Inc NYSE: NHI is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.